We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Advisory Committees Taking Another Look at Ketek
FDA Advisory Committees Taking Another Look at Ketek
November 22, 2006
In the latest round of scrutinizing sanofi-aventis’ antibiotic Ketek, the FDA is holding a joint advisory meeting to address potential health risks associated with the drug.